---
figid: PMC4834358__fonc-06-00085-g002
figlink: /pmc/articles/PMC4834358/figure/F2/
number: F2
caption: The hexosamine biosynthetic pathway (HBP) and glycosylated EMT targets. (A)
  First, the rate limiting enzyme of the HBP, glutamine:fructose-6-phosphate transaminase
  (GFAT), uses glutamine (Gln) as an amine donor to convert Fru-6P into glucosamine-6-P
  (GlcN-6P). Second, glucosamine-phosphate N-acetyltransferase (GNPNAT) N-acetylates
  GlcN-6P in an acetyl-CoA-mediated reaction to form N-acetylglucosamine-6-P (GlcNAc-6P).
  Third, phosphoglucomutase (PGM) isomerizes GlcNAc-6P to the highly active GlcNAc-1P.
  The final step is catalyzed by UDP–N-acetylglucosamine pyrophosphorylase (UAP1)
  and charges GlcNAc-1P with UDP to form uridine-5′-diphosphate-N-acetylglucosamine
  (UDP–GlcNAc). (B) UDP–GlcNAc (depicted as a blue square) is essential for N-glycosylation
  processing and elongation. One critical pivot point includes the branching of complex
  N-glycans. Inhibiting this process with a bisecting GlcNAc is associated with tumor
  suppressive phenotypes. In contrast, cancers have aberrant expression of glycosyltransferases
  responsible for branching and elongating complex N-glycans. (C) Many of the proteins
  commonly associated with promoting EMT are modified by glycans containing GlcNAc
  and are found on the cell surface. Hyaluronan, a glycosaminoglycan, is also found
  extracellularly and is a polymer of glucuronic acid and N-acetylglucosamine. Many
  nuclear, cytoplasmic and mitochondrial proteins are modified by monosaccharides
  of O-linked N-acetylglucosamine (O-GlcNAc), including many transcription factors,
  which appear to be stabilized by glycosylation (). Numerous studies have identified
  various cancers with elevated levels of pan-O-GlcNAcylation ().
pmcid: PMC4834358
papertitle: Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated
  Neoplastic Phenotypes.
reftext: Kekoa Taparra, et al. Front Oncol. 2016;6:85.
pmc_ranked_result_index: '90224'
pathway_score: 0.5252202
filename: fonc-06-00085-g002.jpg
figtitle: Hexosamine biosynthetic pathway (HBP) and glycosylated EMT targets
year: '2016'
organisms: Homo sapiens
ndex: 92c1f3f2-df30-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4834358__fonc-06-00085-g002.html
  '@type': Dataset
  description: The hexosamine biosynthetic pathway (HBP) and glycosylated EMT targets.
    (A) First, the rate limiting enzyme of the HBP, glutamine:fructose-6-phosphate
    transaminase (GFAT), uses glutamine (Gln) as an amine donor to convert Fru-6P
    into glucosamine-6-P (GlcN-6P). Second, glucosamine-phosphate N-acetyltransferase
    (GNPNAT) N-acetylates GlcN-6P in an acetyl-CoA-mediated reaction to form N-acetylglucosamine-6-P
    (GlcNAc-6P). Third, phosphoglucomutase (PGM) isomerizes GlcNAc-6P to the highly
    active GlcNAc-1P. The final step is catalyzed by UDP–N-acetylglucosamine pyrophosphorylase
    (UAP1) and charges GlcNAc-1P with UDP to form uridine-5′-diphosphate-N-acetylglucosamine
    (UDP–GlcNAc). (B) UDP–GlcNAc (depicted as a blue square) is essential for N-glycosylation
    processing and elongation. One critical pivot point includes the branching of
    complex N-glycans. Inhibiting this process with a bisecting GlcNAc is associated
    with tumor suppressive phenotypes. In contrast, cancers have aberrant expression
    of glycosyltransferases responsible for branching and elongating complex N-glycans.
    (C) Many of the proteins commonly associated with promoting EMT are modified by
    glycans containing GlcNAc and are found on the cell surface. Hyaluronan, a glycosaminoglycan,
    is also found extracellularly and is a polymer of glucuronic acid and N-acetylglucosamine.
    Many nuclear, cytoplasmic and mitochondrial proteins are modified by monosaccharides
    of O-linked N-acetylglucosamine (O-GlcNAc), including many transcription factors,
    which appear to be stabilized by glycosylation (). Numerous studies have identified
    various cancers with elevated levels of pan-O-GlcNAcylation ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT10A
  - NOTCH4
  - WNT9B
  - NOTCH1
  - RELA
  - RELB
  - TGFBR3
  - WNT2B
  - WNT9A
  - WNT2
  - WNT16
  - WNT4
  - WNT1
  - WNT8B
  - WNT3
  - NOTCH2
  - NFKB1
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - WNT5B
  - WNT3A
  - CTNNB1
  - WNT5A
  - NOTCH3
  - ADCY2
  - WNT10B
  - WNT11
  - ADCY5
  - CDH2
  - TGFBR2
  - TGFBR1
  - ADCY3
  - NFKB2
  - ADCY4
  - ADCY10
  - WNT7A
  - MYC
  - WNT6
  - ADCY1
  - IHH
  - REL
  - SNAI1
  - SHH
  - GFPT1
  - TP53
  - SMO
  - CDH1
  - WNT7B
  - DHH
  - WNT8A
  - N- Amino Acids
  - Carbohydrates
  - UDP
  - Cancer
genes:
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR3
  entrez: '7049'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: IHH
  entrez: '3549'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: SNAI1
  symbol: SNAI1
  source: hgnc_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: GFAT
  symbol: GFAT
  source: hgnc_alias_symbol
  hgnc_symbol: GFPT1
  entrez: '2673'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: DHH
  entrez: '50846'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
chemicals:
- word: N- Amino Acids
  source: MESH
  identifier: D000596
- word: Carbohydrates
  source: MESH
  identifier: D002241
- word: UDP
  source: MESH
  identifier: D014530
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4834358__F2
redirect_from: /figures/PMC4834358__F2
figtype: Figure
---
